Dr. Satta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 E 74th St
New York, NY 10021Phone+1 646-740-4609
Education & Training
Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 2017 - 2020- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2014 - 2017
- Tokyo Medical and Dental UniversityClass of 2012
Certifications & Licensure
- NY State Medical License 2024 - 2026
VA State Medical License 2019 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsDual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax.Toshihisa Satta, Lin Li, Sri Lakshmi Chalasani, Xiaoyan Hu, Jewel Nkwocha
Clinical Cancer Research. 2023-04-03 - 2 citationsMechanisms underlying synergism between circularized tumor necrosis factor-related apoptosis inducing ligand and bortezomib in bortezomib-sensitive or -resistant myelo...Yun Leng, Xiaoyan Hu, Lin Li, Jewel Nkwocha, Toshihisa Satta
Hematological Oncology. 2022-12-01 - 7 citationsClinical experience of CAR T cells for multiple myeloma.Gary Lee Simmons, Toshihisa Satta, Omar Castaneda Puglianini
Best Practice & Research. Clinical Haematology. 2021-09-01
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
